Cold Crush Childrens
NDC Package 69676-0005-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cold Crush Childrens is uses*addresses symptoms associated with the common cold, such as:chest congestionnasal congestionrunny nosecoughsore throatsneezing. Marketed by Genexa Inc., this product is identified by NDC 69676-0005.

Identification & Billing

NDC Package Code
69676-0005-1
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 60 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
69676-0005
11-Digit Billing Format
69676000501

Clinical Specifications

Proprietary Name
Cold Crush Childrens
Dosage Form
-
Usage Information
Uses*addresses symptoms associated with the common cold, such as:chest congestionnasal congestionrunny nosecoughsore throatsneezing

Regulatory & Marketing

Labeler Name
Genexa Inc.
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
07-03-2018
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69676-0005-1 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 tablet, chewable in 1 bottle, plastic of Cold Crush Childrens, labeled by Genexa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genexa Inc. on July 03, 2018. The current certification is valid through December 31, 2024.

How is this Genexa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69676000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69676-0005-1
11-Digit CMS (5-4-2)
69676-0005-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.